SEC Form 4 Summary UTHR

United Therapeutics CEO Martine A. Rothblatt sells 9,500 shares

United Therapeutics CEO Martine A. Rothblatt sold 9,500 UTHR shares for $5,583,500.99 across 15 transactions.

Transaction Value:
$5,583,500.99
Shares transacted:
9,500
Average price:
$587.74
Insider:

The Form 4 filing, an SEC report of insider stock activity, lists Martine A. Rothblatt as chairperson and CEO. The trades took place on Nov. 16, 2026. The filing followed on Nov. 17, 2026.

Transaction details

Transaction
Date of Earliest Transaction2026-11-16
Date of Latest Transaction2026-11-16
Buy/Sellsell
Transaction Count15
Shares Transacted9,500
Price$587.74
Total Transaction Value$5,583,500.99
Insider
Ticker SymbolUTHR
CompanyUNITED THERAPEUTICS Corp
Insider NameROTHBLATT MARTINE A
Insider TitleChairperson & CEO
Sector - IndustryHealthcare - Drug Manufacturers - Specialty & Generic
Holdings
Total Shares Owned After Transaction324,443
Position Size Change2.84%
Filing
Filing Date2026-11-17
SEC LinkView filing

FAQ

What type of transaction is this?

This was a sale of United Therapeutics (UTHR) shares, reported with transaction code S. The reported activity includes 15 sales by one insider.

What was the average price of the transaction?

The average sale price was $587.74 per share across the 15 transactions. Prices for each individual sale were not provided.

How did this transaction affect the insider's holdings?

Martine A. Rothblatt sold 9,500 shares and reported 324,443 shares owned afterward. The shares sold made up 2.84% of the reported shares held before the sales.

What's the total transaction value?

The total value was $5,583,500.99. It covers all 9,500 shares sold across the 15 reported transactions.

Are there any special circumstances around this transaction?

The available information identifies a Rule 10b5-1 plan reference. Such plans set trading instructions in advance. The filing's footnote text was not provided. It is unclear which of the 15 sales the plan reference covers. The plan's terms and start date are unknown. A plan reference alone does not show whether the trades met the rule's legal requirements.

For research purposes only; not investment advice.

Follow the Newswire
Feedly RSS feed
About RSS

Get new articles in your feed reader as they are published. Add our RSS feed to Feedly or another RSS reader.

Instant SEC Form 4 alerts

Get the next insider trade alert in real time.

Follow the filings behind the headlines. Get matching insider trade alerts sent straight to your email or Telegram, with links to the original SEC filings. Choose Premium for instant alert delivery and ticker-level filters.

Try instant alerts free 10 trading days · No credit card required

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
  • 20 years of alert history
  • Live alert directory updates
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and SEC filing links
  • Access to the alert directory hourly refreshes
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.